ASTH vs PACS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 21, 2026
ASTH
PACS
Investment Advisor Scores
PACS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ASTH | PACS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 8.9686 | 15.528 | ASTH |
| PEG Ratio | 0 | 1.0347 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 48.5% | 9.1% | ASTH |
| Earnings Growth | 110.5% | 51.6% | ASTH |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 50.6/100 | 34.1/100 | ASTH |
| Profit Margin | 1.1% | 4.9% | PACS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | EXTENDED | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ASTH
NeutralMixed signals - no dominant trend phase, RSI 51
PACS
NeutralMixed signals - no dominant trend phase, RSI 61
Fundamentals Snapshot
| Metric | ASTH | PACS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 10.3 | 17.1 |
| Trailing P/E | 46.5 | 27.9 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.5% | 0.1% |
| Gross Margin | 0.1% | 0.2% |
| Operating Margin | 0.0% | 0.1% |
| EPS | 0.83 | 1.71 |
| Dividend Yield | — | — |